Growth and Competition in China's GLP-1 Market

This analytical report explores the rapidly expanding GLP-1 market in China, projected to reach RMB 100 billion by 2030. It highlights key growth drivers, including rising disease prevalence, expanded indications, and increasing public awareness. The report also examines competitive dynamics among global and local pharmaceutical players, along with innovative therapeutic developments. Essential for stakeholders in the healthcare and pharmaceutical sectors, this document provides valuable insight